In terms of promoting NPC growth, we found that TMEM52B‐P18 and TMEM52B‐P20 have a comparable role, both in vitro and in vivo, which is significantly suppressed by PGK1 siRNA pretreatment. The gene discussed is TMEM52B; the disease is nasopharyngeal carcinoma.